ARKADIY CHERNYAK: Open Payments
NPI 1780733147 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 26 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $246 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $206 |
| Teva Pharmaceuticals USA, Inc. | 5 | $89 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: VRAYLAR, AUSTEDO XR, INGREZZA, COBENFY, Rybelsus, REXULTI, TRINTELLIX.
Industry payments across NJ — which companies pay providers there.
